CLEImmunoUpdate
@CLEImmunoUpdate
Followers
23
Following
153
Statuses
55
Updates from Center for Immunotherapy & Precision Immuno-Oncology (CITI @ Cleveland Clinic) | Tweets not of employer
Cleveland, OH
Joined November 2024
RT @Adam_D_Burgener: Dr Daniel McGrail presenting on how the microbiome can affect response to therapy in head and neck cancer in model sys…
0
0
0
RT @LauraBukavinaMD: @CleClinicUro is proud to participate in Quilt2.005 trial offering combination therapy Anktiva BCG vs BCG alone in tr…
0
2
0
RT @nataliesilvermd: Next up is Daniel McGrail PhD sharing our collaborative work on the intratumoral microbiome in head and neck cancer. @…
0
1
0
RT @PGrivasMDPhD: Phenomenal talk by brilliant @shilpaonc on MIBC in #PrecisionOncology meeting in Miami organized by amazing leader @Brain…
0
5
0
RT @PGrivasMDPhD: @DrByronLee gave a great talk @fredhutch on lineage plasticity in bladder Ca! We remembered our time together @ClevelandC…
0
4
0
RT @American_Heart: Today is National #WearRedDay. Let's wear red together for women's heart health. @GoRedForWomen
0
42
0
RT @wkyc: Sasha's Hope: Cleveland Clinic works on breakthrough cancer vaccine for kids (@maureenkyle reports)
0
2
0
RT @caseccc: Learn how the Case Comprehensive Cancer Center works with its partners to conquer cancer for 4 million northeast Ohioans. http…
0
3
0
RT @CleClinicNews: New advancements in medicine are changing the way we treat many diseases. Cellular therapy allows us to use a patient's…
0
3
0
Wonderful work by members of our Immuno-Monitoring Lab and Co-lead of the Precision Oncology Program, Ying Ni
0
0
0
RT @CleClinicMD: New research has identified immunologic factors associated with recurrence in patients with recurrent/metastatic oropharyn…
0
3
0
RT @ACSCAN: The @AmericanCancer Society Cancer Facts & Figures 2025 report is here with data detailing the current cancer burden in the U.S…
0
15
0
RT @jamecancerdoc: Proud to be part of top accruing LAPS network @caseccc @ClevelandClinic along @OhioState @UPMC @theNCI clinica…
0
6
0
Dr. Miller's team created an assay specific for plasma cfHPVDNA detection & prognostic for recurrence, which might be more accessible than dPCR or NGS for longitudinal testing. Link below for more details on this very exciting study- Congrats to the team!
0
0
1
RT @LauraBukavinaMD: Incredible volume, super complex uro-onc care, world-class faculty, and cutting-edge 🔬 —wrapped up in the ultimate fel…
0
7
0
RT @TomMihaljevicMD: We are partnering with @miamiuniversity to establish Ohio’s first specialized degree programs & research experiences i…
0
7
0
RT @NCIDirector: I’ve been @theNCI director for a year – what an exciting one it’s been! In my latest Cancer Currents blog post, I reflect…
0
21
0
RT @jamecancerdoc: Out of 50 drugs approved by @US_FDA about 20 drugs are for hematology and oncology diagnosis! Promising news for our pat…
0
70
0